Home ›
Trademark Categories ›
Pharmaceuticals ›
2022 ›
RI ›
RIMPOVIZ
Trademark search for:
RIMPOVIZ
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2022-05-19 — Application filed
2022-05-23 — Application filed
2022-05-25 — Application filed
2022-12-07 — Assigned to examiner
2022-12-12 — Examiners amendment -written
2022-12-12 — Examiners amendment e-mailed
2022-12-12 — Notification of examiners amendment e-mailed
2022-12-12 — Examiner's amendment entered
2022-12-12 — Approved for pub - principal register
2022-12-28 — Notification of notice of publication e-mailed
2023-01-17 — Published for opposition
2023-01-17 — Official gazette publication confirmation e-mailed
2023-03-14 — Noa e-mailed - sou required from applicant
2023-08-18 — Sou teas extension received
2023-08-18 — Sou extension 1 filed
2023-08-18 — Sou extension 1 granted
2023-08-22 — Notice of approval of extension request e-mailed
2023-11-29 — Sou extension 2 filed
2023-11-29 — Sou extension 2 granted
2023-11-29 — Sou teas extension received
2023-11-30 — Notice of approval of extension request e-mailed
2024-05-30 — Automatic update of assignment of ownership
2024-10-21 — Application abandoned
2024-10-21 — Application abandoned
2024-10-21 — Final status recorded
Owner Information
BIOGEN INTERNATIONAL GMBH
Biogen MA Inc.
Biogen MA Inc.
Correspondent
Douglas A. Rettew FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LL
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
